Metrics as of 10/17/2026, 08:35 AM (Berlin time), refresh in progress.
Butterfly Network, Inc.
Butterfly Network, Inc. is a healthcare company specializing in the invention, production, and global commercialization of advanced ultrasound imaging technologies. The product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-7.6%
1W
-12.1%
1M
-0.1%
6M
+33.0%
YTD
+90.8%
1Y
+223.7%
2Y
+321.5%
5Y
-31.9%
10Y
–
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~63% stronger price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
3 more assignments (Enabler/Second row) Pro-only.
Butterfly Network is a Digital Health company specializing in the development and global distribution of cutting-edge ultrasound technologies. Its product portfolio comprises portable ultrasound systems such as the Butterfly iQ and the Butterfly Blueprint platform, which seamlessly integrates proprietary software into clinical infrastructure. The business model relies on a hybrid approach, combining hardware sales - including probes and accessories - with cloud-based software solutions. These encompass teleguidance services, educational modules via the Butterfly Academy, and clinical support. Products are distributed through a multi-channel system consisting of direct sales, distributors, and e-commerce. A significant portion of revenues also derives from software subscriptions for healthcare organizations.
PRICE TARGET LOW
US$10.00
CONSENSUS
US$11.67
MEDIAN
US$10.00
PRICE TARGET HIGH
US$15.00
0
STRONG BUY
6
BUY
1
HOLD
0
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 11/09/2026
P/E
-25.05
P/B
10.03
EV/EBITDA
-27.52
RETURN ON EQUITY
-6.8%
NET MARGIN
-39.6%
DEBT/EQUITY
0.1
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
81.2%
FLOAT SHARES
216,186,597
AVG. DAILY VOLUME (30D)
5,480,245
NOONEN MICHAEL
DEVIVO JOSEPH
Carlson Megan
DEVIVO JOSEPH
DEVIVO JOSEPH
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -7.6%
Forums (Reddit)
Butterfly Network, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Joseph DeVivo, the company employs around 220 people.
The IPO was on 13/07/2020; the stock trades on NYSE under the ticker BFLY.
7 analysts rate the stock, the consensus is Buy (as of 11/09/2026).
The average price target is US$11.67, ranging from US$10.00 to US$15.00, with a median of US$10.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 63% stronger than usual.
No, Butterfly Network currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess Butterfly Network against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.